University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Igor Barani, M.D.

Radiation cancer specialist

Dr. Igor Barani is a radiation cancer specialist with a particular interest in the treatment of cancer of the brain and central nervous system. He specializes in the use of radiosurgical techniques, such as the Cyberknife, to treat adults and children with malignant and benign conditions. He's also interested in the development and implementation of new treatments for brain tumors, especially treatments that preserve brain and other neurologic function.

Barani's research revolves around neural stem cells and their potential roles in the development of gliomas, which is cancer of the brain or spine, as well as neurocognitive decline after treatment. The study of treatment-related side effects is increasingly important as the number of long-term survivors of childhood and adult brain tumors increases with improved therapies. Barani is exploring neural stem cell biology and modern treatment techniques to benefit patients with central nervous system tumors. He is an assistant professor of radiation oncology at UCSF.

Clinics

Radiation Oncology at Parnassus
505 Parnassus Ave, Room L-75
San Francisco, CA 94143-0226
Main Phone: (415) 353-7175
New Patient Appointments: (415) 353-8335
Fax: (415) 353-7281

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Conditions & Treatments

More about Igor Barani

Education

SUNY, Syracuse School of Medicine 2003

Residencies

Virginia Commonwealth University School of Medicine, Radiation Oncology 2008

Selected Research and Publications

  1. Huang T, Mueller S, Rutkowski MJ, Han SJ, Bloch O, Barani IJ, Parsa AT, Chang SM. Multidisciplinary care of patients with brain tumors. Surg Oncol Clin N Am. 2013 Apr; 22(2):161-78.
  2. Johnson J, Barani IJ. Radiotherapy for malignant tumors of the skull base. Neurosurg Clin N Am. 2013 Jan; 24(1):125-35.
  3. Fogh S, Ma L, Gupta N, Sahgal A, Nakamura JL, Barani I, Sneed PK, McDermott M, Larson DA. High-precision volume-staged Gamma Knife surgery and equivalent hypofractionation dose schedules for treating large arteriovenous malformations. J Neurosurg. 2012 Dec; 117 Suppl:115-9.
  4. Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S. Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro Oncol. 2013 Jan; 15(1):91-6.
  5. Bloch O, Sun M, Kaur G, Barani IJ, Parsa AT. Fractionated radiotherapy for optic nerve sheath meningiomas. J Clin Neurosci. 2012 Sep; 19(9):1210-5.
  6. Mills SA, Oh MC, Rutkowski MJ, Sughrue ME, Barani IJ, Parsa AT. Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease. Neuro Oncol. 2012 Aug; 14(8):1097-104.
  7. Han SJ, Oh MC, Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, Parsa AT. The effect of the 2003 Consensus Reporting Standards on publications describing patients with vestibular schwannoma treated with stereotactic radiosurgery. J Clin Neurosci. 2012 Aug; 19(8):1144-7.
  8. Ivan ME, Cheng JS, Kaur G, Sughrue ME, Clark A, Kane AJ, Aranda D, McDermott M, Barani IJ, Parsa AT. Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas. J Neurol Surg B Skull Base. 2012 Feb; 73(1):76-83.
  9. Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Int J Radiat Oncol Biol Phys. 2012 May 1; 83(1):303-9.
  10. Ma L, Lee L, Barani I, Hwang A, Fogh S, Nakamura J, McDermott M, Sneed P, Larson DA, Sahgal A. Shot sequencing based on biological equivalent dose considerations for multiple isocenter Gamma Knife radiosurgery. Phys Med Biol. 2011 Nov 21; 56(22):7247-56.
  11. Bloch O, Kaur G, Jian BJ, Parsa AT, Barani IJ. Stereotactic radiosurgery for benign meningiomas. J Neurooncol. 2012 Mar; 107(1):13-20.
  12. Lupo JM, Chuang CF, Chang SM, Barani IJ, Jimenez B, Hess CP, Nelson SJ. 7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys. 2012 Mar 1; 82(3):e493-500.
  13. Kirby N, Chuang C, Pouliot J, Hwang A, Barani IJ. Physics strategies for sparing neural stem cells during whole-brain radiation treatments. Med Phys. 2011 Oct; 38(10):5338-44.
  14. Rutkowski MJ, Bloch O, Jian BJ, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT. Management of recurrent intracranial hemangiopericytoma. J Clin Neurosci. 2011 Nov; 18(11):1500-4.
  15. Rutkowski MJ, Jian BJ, Bloch O, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT. Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer. 2012 Mar 15; 118(6):1628-36.
  16. Ma L, Sahgal A, Hwang A, Hu W, Descovich M, Chuang C, Barani I, Sneed PK, McDermott M, Larson DA. A two-step optimization method for improving multiple brain lesion treatments with robotic radiosurgery. Technol Cancer Res Treat. 2011 Aug; 10(4):331-8.
  17. Tate M, Sughrue ME, Rutkowski MJ, Kane AJ, Aranda D, McClinton L, McClinton L, Barani IJ, Parsa AT. The long-term postsurgical prognosis of patients with pineoblastoma. Cancer. 2012 Jan 1; 118(1):173-9.
  18. Todor DA, Barani IJ, Lin PS, Anscher MS. Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution. Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):297-304.
  19. Sughrue ME, Choi J, Rutkowski MJ, Aranda D, Kane AJ, Barani IJ, Parsa AT. Clinical features and post-surgical outcome of patients with astroblastoma. J Clin Neurosci. 2011 Jun; 18(6):750-4.
  20. Ma L, Petti P, Wang B, Descovich M, Chuang C, Barani IJ, Kunwar S, Shrieve DC, Sahgal A, Larson DA. Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg. 2011 Jun; 114(6):1580-4.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.